Guardant Health
GH
#1708
Rank
โ‚น1.113 T
Marketcap
โ‚น8,486
Share price
-1.32%
Change (1 day)
133.29%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น289.89

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น308.16. In 2024 the company made an earnings per share (EPS) of -โ‚น331.44 an increase over its 2023 EPS that were of -โ‚น398.47.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น289.89-12.53%
2024-โ‚น331.44-16.82%
2023-โ‚น398.47-33.13%
2022-โ‚น595.8460%
2021-โ‚น372.4055.04%
2020-โ‚น240.20207.14%
2019-โ‚น78.20-19.81%
2018-โ‚น97.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น258.54-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น199.23-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA